SlideShare a Scribd company logo
1 of 20
Download to read offline
2Q13 Conference Call Presentation
August 15, 2013
• Gross revenues of R$845.4 million, an increase of 13.2% over 2Q12.
• Gross Margin of 31.5%, 1.4 p.p. over 2Q12
• Total SSS (same-store sales) of 9.8%, with 5.3% for mature stores
• Adjusted EBITDA of R$48.4 million, with adjusted EBITDA margin of 5.7%
• Adjusted net income of R$7.9 million, with adjusted net margin of 0.9%
• With the opening of 25 new owned stores and 27 franchisees, we ended 2Q13 with 1,160 stores.
• Inauguration of a new distribution center in Recife
Operational & Financial
250 Owned stores
121 Owned stores
143 Owned stores
433 Franchises
213 Owned stores
727 Owned stores
433 Franchises
1,160 stores
REGIONS
Owned stores
North 128
Northeast 249
Midwest 137
Southeast
South 213
15
2
120
20
15
28
13
201
8
69
122
1
12
5 Distribution centers
95
6
National Footprint
 25 openings (34 in 1H13)
7 closings (15 in 1H13)
 39.5% of owned stores not yet at mature
stage
25
7
12.4%
14.4%
12.7%60.5%
Stores with less than 12 months
Stores with 12 to 24 months
Stores with 24 to 36 months
Stores with more than 36 months
• 27 openings in 2Q13
• Accelerated expansion plan
18.4%
12.0%
24.0%
14.0%
1H12 1H13
Abrafarma chains
Brasil Pharma
746.9
845.4
1,446.2
1,648.9
2Q12 2Q13 1H12 1H13
13.8%
9.8%
9.1%
5.3%
2Q12 2Q13
SSS Total
SSS mature stores (36 months or older)
10.2% 9.8% 9.3%
8.0%
6.9%
4.3% 3.7% 3.0%
0.6%
-19.0%
Generic penetration in medicine sales
36.5% 37.1% 38.4% 37.9% 37.6%
17.1% 17.0% 16.4% 16.5% 16.9%
46.4% 45.9% 45.2% 45.6% 45.5%
2Q12 3Q12 4Q12 1Q13 2Q13
Non-medicines Generic Medicine Branded medicine
31.4
33.8
2Q12 2Q13
• Higher “pre- increase” effect in 2Q13 compared to 2Q12
• Distribution Center in Bahia
224.5
266.0
435.5
499.0
30.1%
31.5%
30.1% 30.3%
2Q12 2Q13 1H12 1H13
51,9 51,0
103,4 99,1
126,2 166,6
249,0
316,7178,1
217,6
352,3
415,8
2Q12 2Q13 1H12 1H13
General & Administrative Sales expenses
6,9% 6,0% 7,1% 6,0%
16,9%
19,7%
17,2%
19,2%
23,8%
25,7%
24,4% 25,2%
2Q12 2Q13 1H12 1H13
G&A % Sales expenses % SG&A total %
2Q12 2Q13 1H12 1H13
Proforma
Gross Revenues 746,855 845,424 1,446,204 1,648,891
General and administrative expenses (G&A) (51,889) (50,994) (103,353) (99,117)
% Gross Revenues 6.9% 6.0% 7.1% 6.0%
G&ADilution (R$'000)
1H12 1H13
Proforma Proforma
Non recurring SG&A (3,721) - 14,513 (2,594)
IPO /Debenture issuance expenses - (108) -
M&A/Branding (397) (2,204) (684)
Income related to Santana insurance - 21,653 -
Platforms Integration/Downsizing (3,324) (4,828) (1,763)
Other - - (147)
Non recurring expenses (R$'000) 2Q12 2Q13
46,3 48,4
83,2 83,2
6,2%
5,7% 5,8%
5,0%
2Q12 2Q13 1H12 1H13
24,3
7,9
34,4
10,4
3,2%
0,9%
2,4%
0,6%
2Q12 2Q13 1H12 1H13
Cash position and indebtedness (R$'000) 2Q12 4Q12 1Q13 2Q13
(+) Loans and financing 159,908 177,049 169,079 160,228
Short term 48,123 83,229 44,864 41,694
Long term 111,785 93,820 124,215 118,534
(+) Debentures 254,879 253,642 258,937 253,964
Short term 6,688 5,237 10,427 5,348
Long term 248,191 248,405 248,510 248,616
(+) Accounts payable for investment acquisition 498,242 345,333 264,430 232,581
Short term 244,986 99,711 82,833 81,986
Long term 253,256 245,622 181,597 150,595
(=) Total Indebtedness 913,029 776,024 692,446 646,773
Short term (%) 32.8% 24.2% 19.9% 19.9%
Long term (%) 67.2% 75.8% 80.1% 80.1%
(-) Cash and cash equivalents (411,267) (368,751) (183,870) (162,205)
(=) Net Debt 501,762 407,273 508,576 484,568
Net debt/Adjusted EBITDA (LTM) 2.9 X 2.1 X 2.7 X 2.5 X
746
6
27
12
23
Working capial 2Q12 4Q12 1Q13 2Q13
Accounts receivable 25 23 24 18
Inventories 92 95 106 109
Suppliers 54 58 55 73
Working capital in days 63 60 75 53
Cash flow Statement (R$'000) 2Q12 2Q13 1H12 1H13
EBT 7,795 11,158 18,021 3,605
(+) Depreciation and amortization 12,268 17,054 28,360 33,516
(+) Others 12,896 (4,175) 26,038 20,214- -
Operating cash generation 32,959 24,037 72,419 57,335
(+) Change in working capital (93,559) 159,077 (151,092) 75,935
(+) Change in other assets and liabilities (41,623) (104,886) (55,541) (118,669)
Cash consumption (135,182) 54,191 (206,633) (42,734)
Net cash generated by operating activities (102,223) 78,228 (134,214) 14,601
(-) Capex from operations (28,176) (49,033) (47,723) (73,953)
(-) Acquisitions (41,566) (31,848) (327,898) (112,751)
Net Cash from investing activities (69,742) (80,881) (375,621) (186,704)
(+/-) Loans and financing 62,480 (25,986) 258,755 (41,417)
(+) Equity funding / Dividends 397,851 6,975 398,792 6,975
Net Cash from financing activities 460,331 (19,011) 657,547 (34,442)
Change in cash and cash equivalents 288,366 (21,664) 147,712 (206,545)
Cash and cash equivalents - opening balance 122,901 183,870 263,555 368,751
Cash and cash equivalents - closing balance 411,267 162,205 411,267 162,205
Back-Office Adm. (SSC) SAP - Back-Office
Operation integrated (SSC).
Continuous improvement phase
Pre-"Go Live" tests cycle
Will be integrated in 2014
Mapping phase and "Go live" in
2014
Operation integrated (SSC).
Continuous improvement phase
Pre-"Go Live" tests cycle
Operation integrated (SSC).
Continuous improvement phase
Pre-"Go Live" tests cycle
Status 75% 50%
Administrative (SSC)
Logistics Trade Marketing Procurement
New DC
(Nov 2012)
Stores remodeling (2012):
28% increase in HPC
Procurement integrated
New DC
(Jun 2013)
Actions to improve generics
sales in practice
Procurement Integration
expected to 2014
New DC
FC (Out 2013)
Focus in remodeling to
standardize mix and layout
Procurement integrated
New DC
(Out 2012)
Mix and store layout
standardized
Procurement integrated
Status 70% 60% 60%
Commercial
Sales Training Culture Meritocracy POS system Growth strategy
"Vendo Mais" Program
in practice
New Brasil Pharma logo
(endorsement)
Standardization of
variable compensation
implemented
Unique system under
analysis
Store openings:
countryside of Bahia
"Vendo Mais" Program
in practice
New Brasil Pharma logo
(endorsement)
Standardization of
variable compensation
to be implemented
Unique system under
analysis
Store openings in N/NE
"Vendo Mais" Program
in practice
New Brasil Pharma logo
(endorsement)
Standardization of
variable compensation
implemented
Unique system under
analysis
Store closings: sales
bellow BRPH average
"Vendo Mais" Program
in practice
New Brasil Pharma logo
(endorsement)
Standardization of
variable compensation
implemented
Unique system under
analysis
Store openings:
countryside of MT and
GO
Status 100% 100% 80% 0% 80%
Operations
Jun-11
Jul-11
Aug-11
Sep-11
Oct-11
Nov-11
Dec-11
Jan-12
Feb-12
Mar-12
Apr-12
May-12
Jun-12
Jul-12
Aug-12
Sep-12
Oct-12
Nov-12
Dec-12
Jan-13
Feb-13
Mar-13
Apr-13
May-13
Jun-13
Brasil Pharma
IBOV
Source: Bloomberg, as of June 30st, 2013.
Company’s IPO on June 24, 2011.
BPHA3 06.31.13 Market closure
Shares outstanding 256,084,419
Price (R$/share) 10.26
Annual Performance -28.8%
Ibovespa Index -22.1%
Perfomance since IPO¹ 19.0%
Ibovespa Index -22.2%
Market Cap (R$ Bn) 2.6
Average daily trading volume in 2013 (R$ million) 12.4
BPHA3 06.31.13 Market closure
Shares outstanding 256,084,419
Price (R$/share) 10.26
Annual Performance -28.8%
Ibovespa Index -22.1%
Perfomance since IPO¹ 19.0%
Ibovespa Index -22.2%
Market Cap (R$ Bn) 2.6
Average daily trading volume in 2013 (R$ million) 12.4
256,384,419
06.30.13
Brph apresentação call 2 t13 (eng) v2
Brph apresentação call 2 t13 (eng) v2

More Related Content

What's hot

Husqvarna Group results q2 2014
Husqvarna Group results q2 2014Husqvarna Group results q2 2014
Husqvarna Group results q2 2014Husqvarna Group
 
Husqvarna Group Q1 2016 results presentation
Husqvarna Group Q1 2016 results presentationHusqvarna Group Q1 2016 results presentation
Husqvarna Group Q1 2016 results presentationHusqvarna Group
 
SGS 2018 Half Year Results Presentation
SGS 2018 Half Year Results PresentationSGS 2018 Half Year Results Presentation
SGS 2018 Half Year Results PresentationSGS
 
Q1 2015 husqvarna 16 9 final
Q1 2015 husqvarna 16 9 finalQ1 2015 husqvarna 16 9 final
Q1 2015 husqvarna 16 9 finalHusqvarna Group
 
SGS 2021 Full Year Results Alternative Performance Measures
SGS 2021 Full Year Results Alternative Performance MeasuresSGS 2021 Full Year Results Alternative Performance Measures
SGS 2021 Full Year Results Alternative Performance MeasuresSGS
 
Husqvarna Group Q2 Results Presentation
Husqvarna Group Q2 Results PresentationHusqvarna Group Q2 Results Presentation
Husqvarna Group Q2 Results PresentationHusqvarna Group
 
Cia. Hering 4Q13 earnings presentation
Cia. Hering 4Q13 earnings presentationCia. Hering 4Q13 earnings presentation
Cia. Hering 4Q13 earnings presentationCia Hering RI
 
2014 year-end results presentation slides
2014 year-end results presentation slides2014 year-end results presentation slides
2014 year-end results presentation slidesmcschoeman
 
Hgtx presentation 4 q14 eng
Hgtx presentation 4 q14 engHgtx presentation 4 q14 eng
Hgtx presentation 4 q14 engCia Hering RI
 
SGS 2021 Half Year Results Alternative Performance Measures Report
SGS 2021 Half Year Results Alternative Performance Measures ReportSGS 2021 Half Year Results Alternative Performance Measures Report
SGS 2021 Half Year Results Alternative Performance Measures ReportSGS
 
SGS 2020 Half Year Results Presentation
SGS 2020 Half Year Results PresentationSGS 2020 Half Year Results Presentation
SGS 2020 Half Year Results PresentationSGS
 
Q4 2015 earnings conference call presentation 24 2_16_final
Q4 2015 earnings conference call presentation 24 2_16_finalQ4 2015 earnings conference call presentation 24 2_16_final
Q4 2015 earnings conference call presentation 24 2_16_finalMyers_Investors
 
Q2 2014 earnings conference call presentation final
Q2 2014 earnings conference call presentation finalQ2 2014 earnings conference call presentation final
Q2 2014 earnings conference call presentation finalMyers_Investors
 
Q1 2017 Earnings Deck Final
Q1 2017 Earnings Deck FinalQ1 2017 Earnings Deck Final
Q1 2017 Earnings Deck Finalgreif2015
 
Apresentação 4 t13_eng_vf (1)
Apresentação 4 t13_eng_vf (1)Apresentação 4 t13_eng_vf (1)
Apresentação 4 t13_eng_vf (1)Gafisa RI !
 
Wrk may 2017 investor presentation v final
Wrk may 2017 investor presentation v finalWrk may 2017 investor presentation v final
Wrk may 2017 investor presentation v finalir_westrock
 
3Q13 Earnings Presentation
3Q13 Earnings Presentation3Q13 Earnings Presentation
3Q13 Earnings Presentationfamilydollar22
 

What's hot (18)

Husqvarna Group results q2 2014
Husqvarna Group results q2 2014Husqvarna Group results q2 2014
Husqvarna Group results q2 2014
 
Husqvarna Group Q1 2016 results presentation
Husqvarna Group Q1 2016 results presentationHusqvarna Group Q1 2016 results presentation
Husqvarna Group Q1 2016 results presentation
 
SGS 2018 Half Year Results Presentation
SGS 2018 Half Year Results PresentationSGS 2018 Half Year Results Presentation
SGS 2018 Half Year Results Presentation
 
Q1 2015 husqvarna 16 9 final
Q1 2015 husqvarna 16 9 finalQ1 2015 husqvarna 16 9 final
Q1 2015 husqvarna 16 9 final
 
SGS 2021 Full Year Results Alternative Performance Measures
SGS 2021 Full Year Results Alternative Performance MeasuresSGS 2021 Full Year Results Alternative Performance Measures
SGS 2021 Full Year Results Alternative Performance Measures
 
Husqvarna Group Q2 Results Presentation
Husqvarna Group Q2 Results PresentationHusqvarna Group Q2 Results Presentation
Husqvarna Group Q2 Results Presentation
 
Presentation 2013
Presentation 2013Presentation 2013
Presentation 2013
 
Cia. Hering 4Q13 earnings presentation
Cia. Hering 4Q13 earnings presentationCia. Hering 4Q13 earnings presentation
Cia. Hering 4Q13 earnings presentation
 
2014 year-end results presentation slides
2014 year-end results presentation slides2014 year-end results presentation slides
2014 year-end results presentation slides
 
Hgtx presentation 4 q14 eng
Hgtx presentation 4 q14 engHgtx presentation 4 q14 eng
Hgtx presentation 4 q14 eng
 
SGS 2021 Half Year Results Alternative Performance Measures Report
SGS 2021 Half Year Results Alternative Performance Measures ReportSGS 2021 Half Year Results Alternative Performance Measures Report
SGS 2021 Half Year Results Alternative Performance Measures Report
 
SGS 2020 Half Year Results Presentation
SGS 2020 Half Year Results PresentationSGS 2020 Half Year Results Presentation
SGS 2020 Half Year Results Presentation
 
Q4 2015 earnings conference call presentation 24 2_16_final
Q4 2015 earnings conference call presentation 24 2_16_finalQ4 2015 earnings conference call presentation 24 2_16_final
Q4 2015 earnings conference call presentation 24 2_16_final
 
Q2 2014 earnings conference call presentation final
Q2 2014 earnings conference call presentation finalQ2 2014 earnings conference call presentation final
Q2 2014 earnings conference call presentation final
 
Q1 2017 Earnings Deck Final
Q1 2017 Earnings Deck FinalQ1 2017 Earnings Deck Final
Q1 2017 Earnings Deck Final
 
Apresentação 4 t13_eng_vf (1)
Apresentação 4 t13_eng_vf (1)Apresentação 4 t13_eng_vf (1)
Apresentação 4 t13_eng_vf (1)
 
Wrk may 2017 investor presentation v final
Wrk may 2017 investor presentation v finalWrk may 2017 investor presentation v final
Wrk may 2017 investor presentation v final
 
3Q13 Earnings Presentation
3Q13 Earnings Presentation3Q13 Earnings Presentation
3Q13 Earnings Presentation
 

Viewers also liked

4 q11 results conference call presentation
4 q11 results   conference call presentation4 q11 results   conference call presentation
4 q11 results conference call presentationbrpharma
 
3 q12 results conference call presentation
3 q12 results   conference call presentation3 q12 results   conference call presentation
3 q12 results conference call presentationbrpharma
 
Bradesco ceo conf brph_presentation (26 11 12)
Bradesco ceo conf brph_presentation (26 11 12)Bradesco ceo conf brph_presentation (26 11 12)
Bradesco ceo conf brph_presentation (26 11 12)brpharma
 
DaVita -Celebrating National Nutrition Month ® 2014. Connecting Our Village ...
DaVita -Celebrating National Nutrition Month ® 2014.  Connecting Our Village ...DaVita -Celebrating National Nutrition Month ® 2014.  Connecting Our Village ...
DaVita -Celebrating National Nutrition Month ® 2014. Connecting Our Village ...Jennifer Snyder
 
4 q12 results presentation
4 q12 results presentation4 q12 results presentation
4 q12 results presentationbrpharma
 
Brph ceo conference (04.10.13) v3
Brph ceo conference (04.10.13) v3Brph ceo conference (04.10.13) v3
Brph ceo conference (04.10.13) v3brpharma
 
Brazil pharma march 2012
Brazil pharma march 2012Brazil pharma march 2012
Brazil pharma march 2012brpharma
 
Informace o právech a povinnostech studentů
Informace o právech a povinnostech studentůInformace o právech a povinnostech studentů
Informace o právech a povinnostech studentůTomáš Mejzlík
 
American icons of the great war
American icons of the great warAmerican icons of the great war
American icons of the great warKatie Latham
 
Join DaVita Dietitians in celebrating National Nutrition Month® March 2015
Join DaVita Dietitians in celebrating National Nutrition Month® March 2015Join DaVita Dietitians in celebrating National Nutrition Month® March 2015
Join DaVita Dietitians in celebrating National Nutrition Month® March 2015Jennifer Snyder
 
Irregulars verbs
Irregulars verbsIrregulars verbs
Irregulars verbsnnnerea
 
The Kingfisher Saga
The Kingfisher SagaThe Kingfisher Saga
The Kingfisher SagaSumati Joshi
 
Indian Refrigerator Market
Indian Refrigerator MarketIndian Refrigerator Market
Indian Refrigerator MarketSumati Joshi
 
Cement & construction
Cement & constructionCement & construction
Cement & constructionSumati Joshi
 
ITC Rural Marketing
ITC Rural MarketingITC Rural Marketing
ITC Rural MarketingSumati Joshi
 
02 1-tutores virtuales
02 1-tutores virtuales02 1-tutores virtuales
02 1-tutores virtualestatygonza222
 

Viewers also liked (19)

4 q11 results conference call presentation
4 q11 results   conference call presentation4 q11 results   conference call presentation
4 q11 results conference call presentation
 
3 q12 results conference call presentation
3 q12 results   conference call presentation3 q12 results   conference call presentation
3 q12 results conference call presentation
 
Bradesco ceo conf brph_presentation (26 11 12)
Bradesco ceo conf brph_presentation (26 11 12)Bradesco ceo conf brph_presentation (26 11 12)
Bradesco ceo conf brph_presentation (26 11 12)
 
DaVita -Celebrating National Nutrition Month ® 2014. Connecting Our Village ...
DaVita -Celebrating National Nutrition Month ® 2014.  Connecting Our Village ...DaVita -Celebrating National Nutrition Month ® 2014.  Connecting Our Village ...
DaVita -Celebrating National Nutrition Month ® 2014. Connecting Our Village ...
 
4 q12 results presentation
4 q12 results presentation4 q12 results presentation
4 q12 results presentation
 
Brph ceo conference (04.10.13) v3
Brph ceo conference (04.10.13) v3Brph ceo conference (04.10.13) v3
Brph ceo conference (04.10.13) v3
 
Brazil pharma march 2012
Brazil pharma march 2012Brazil pharma march 2012
Brazil pharma march 2012
 
Informace o právech a povinnostech studentů
Informace o právech a povinnostech studentůInformace o právech a povinnostech studentů
Informace o právech a povinnostech studentů
 
American icons of the great war
American icons of the great warAmerican icons of the great war
American icons of the great war
 
Join DaVita Dietitians in celebrating National Nutrition Month® March 2015
Join DaVita Dietitians in celebrating National Nutrition Month® March 2015Join DaVita Dietitians in celebrating National Nutrition Month® March 2015
Join DaVita Dietitians in celebrating National Nutrition Month® March 2015
 
Irregulars verbs
Irregulars verbsIrregulars verbs
Irregulars verbs
 
Cape verde
Cape verdeCape verde
Cape verde
 
Lenguaje
LenguajeLenguaje
Lenguaje
 
The Kingfisher Saga
The Kingfisher SagaThe Kingfisher Saga
The Kingfisher Saga
 
Indian Refrigerator Market
Indian Refrigerator MarketIndian Refrigerator Market
Indian Refrigerator Market
 
Cement & construction
Cement & constructionCement & construction
Cement & construction
 
ITC Rural Marketing
ITC Rural MarketingITC Rural Marketing
ITC Rural Marketing
 
02 1-tutores virtuales
02 1-tutores virtuales02 1-tutores virtuales
02 1-tutores virtuales
 
E commerce
E commerceE commerce
E commerce
 

Similar to Brph apresentação call 2 t13 (eng) v2

Brph apresentação call 4 t13 (eng) (3)
Brph apresentação call 4 t13 (eng) (3)Brph apresentação call 4 t13 (eng) (3)
Brph apresentação call 4 t13 (eng) (3)brpharma
 
Brph apresentação call 2 t14 (eng)
Brph apresentação call 2 t14 (eng)Brph apresentação call 2 t14 (eng)
Brph apresentação call 2 t14 (eng)brpharma
 
Brph apresentação call 1 t13 (eng) v5
Brph apresentação call 1 t13 (eng) v5Brph apresentação call 1 t13 (eng) v5
Brph apresentação call 1 t13 (eng) v5brpharma
 
Brph apresentação call 1 t13 (eng) v5
Brph apresentação call 1 t13 (eng) v5Brph apresentação call 1 t13 (eng) v5
Brph apresentação call 1 t13 (eng) v5brpharma
 
Brph apresentação call 1 t13 (eng) v5
Brph apresentação call 1 t13 (eng) v5Brph apresentação call 1 t13 (eng) v5
Brph apresentação call 1 t13 (eng) v5brpharma
 
Brphapresentaocall1t14engv11 140515080726-phpapp01
Brphapresentaocall1t14engv11 140515080726-phpapp01Brphapresentaocall1t14engv11 140515080726-phpapp01
Brphapresentaocall1t14engv11 140515080726-phpapp01brpharma
 
Brph apresentação call 4 t13 (eng)
Brph apresentação call 4 t13 (eng)Brph apresentação call 4 t13 (eng)
Brph apresentação call 4 t13 (eng)brpharma
 
Estácio: 1Q15 Conference Call Presentation
Estácio: 1Q15 Conference Call PresentationEstácio: 1Q15 Conference Call Presentation
Estácio: 1Q15 Conference Call PresentationEstácio Participações
 
Brph apresentação call 3 t13 (eng)
Brph apresentação call 3 t13 (eng)Brph apresentação call 3 t13 (eng)
Brph apresentação call 3 t13 (eng)brpharma
 
Brph apresentação call 3 t13 (eng)
Brph apresentação call 3 t13 (eng)Brph apresentação call 3 t13 (eng)
Brph apresentação call 3 t13 (eng)brpharma
 
Financial Analysis with Microsoft Excel 7th Edition Mayes Solutions Manual
Financial Analysis with Microsoft Excel 7th Edition Mayes Solutions ManualFinancial Analysis with Microsoft Excel 7th Edition Mayes Solutions Manual
Financial Analysis with Microsoft Excel 7th Edition Mayes Solutions Manualtuqykogod
 
Estácio: 4Q14 and 2014 Conference Call Presentation
Estácio: 4Q14 and 2014 Conference Call PresentationEstácio: 4Q14 and 2014 Conference Call Presentation
Estácio: 4Q14 and 2014 Conference Call PresentationEstácio Participações
 
Qliro Group Q4 and year-end results 2016
Qliro Group Q4 and year-end  results 2016Qliro Group Q4 and year-end  results 2016
Qliro Group Q4 and year-end results 2016qlirogroup
 
Brph apresentação call 3 q14 (eng)
Brph apresentação call 3 q14 (eng)Brph apresentação call 3 q14 (eng)
Brph apresentação call 3 q14 (eng)brpharma
 
Press release presentation 3 q15
Press release presentation 3 q15Press release presentation 3 q15
Press release presentation 3 q15Juliana Arutin
 
Gafisa 1 q14 teleconf eng vf (1)
Gafisa 1 q14 teleconf  eng vf (1)Gafisa 1 q14 teleconf  eng vf (1)
Gafisa 1 q14 teleconf eng vf (1)Gafisa RI !
 
4 t15 arezzo_apresentacao_call ing
4 t15 arezzo_apresentacao_call ing4 t15 arezzo_apresentacao_call ing
4 t15 arezzo_apresentacao_call ingArezzori
 
Current Years Estimation PowerPoint Presentation Slides
Current Years Estimation PowerPoint Presentation SlidesCurrent Years Estimation PowerPoint Presentation Slides
Current Years Estimation PowerPoint Presentation SlidesSlideTeam
 
Estácio: 2Q16 Conference Call Presentation
Estácio: 2Q16 Conference Call PresentationEstácio: 2Q16 Conference Call Presentation
Estácio: 2Q16 Conference Call PresentationEstácio Participações
 

Similar to Brph apresentação call 2 t13 (eng) v2 (20)

Brph apresentação call 4 t13 (eng) (3)
Brph apresentação call 4 t13 (eng) (3)Brph apresentação call 4 t13 (eng) (3)
Brph apresentação call 4 t13 (eng) (3)
 
Brph apresentação call 2 t14 (eng)
Brph apresentação call 2 t14 (eng)Brph apresentação call 2 t14 (eng)
Brph apresentação call 2 t14 (eng)
 
Brph apresentação call 1 t13 (eng) v5
Brph apresentação call 1 t13 (eng) v5Brph apresentação call 1 t13 (eng) v5
Brph apresentação call 1 t13 (eng) v5
 
Brph apresentação call 1 t13 (eng) v5
Brph apresentação call 1 t13 (eng) v5Brph apresentação call 1 t13 (eng) v5
Brph apresentação call 1 t13 (eng) v5
 
Brph apresentação call 1 t13 (eng) v5
Brph apresentação call 1 t13 (eng) v5Brph apresentação call 1 t13 (eng) v5
Brph apresentação call 1 t13 (eng) v5
 
Brphapresentaocall1t14engv11 140515080726-phpapp01
Brphapresentaocall1t14engv11 140515080726-phpapp01Brphapresentaocall1t14engv11 140515080726-phpapp01
Brphapresentaocall1t14engv11 140515080726-phpapp01
 
Brph apresentação call 4 t13 (eng)
Brph apresentação call 4 t13 (eng)Brph apresentação call 4 t13 (eng)
Brph apresentação call 4 t13 (eng)
 
Estácio: 1Q15 Conference Call Presentation
Estácio: 1Q15 Conference Call PresentationEstácio: 1Q15 Conference Call Presentation
Estácio: 1Q15 Conference Call Presentation
 
Brph apresentação call 3 t13 (eng)
Brph apresentação call 3 t13 (eng)Brph apresentação call 3 t13 (eng)
Brph apresentação call 3 t13 (eng)
 
Brph apresentação call 3 t13 (eng)
Brph apresentação call 3 t13 (eng)Brph apresentação call 3 t13 (eng)
Brph apresentação call 3 t13 (eng)
 
Financial Analysis with Microsoft Excel 7th Edition Mayes Solutions Manual
Financial Analysis with Microsoft Excel 7th Edition Mayes Solutions ManualFinancial Analysis with Microsoft Excel 7th Edition Mayes Solutions Manual
Financial Analysis with Microsoft Excel 7th Edition Mayes Solutions Manual
 
Estácio: 4Q14 and 2014 Conference Call Presentation
Estácio: 4Q14 and 2014 Conference Call PresentationEstácio: 4Q14 and 2014 Conference Call Presentation
Estácio: 4Q14 and 2014 Conference Call Presentation
 
Q2 results overview 2014
Q2 results overview 2014Q2 results overview 2014
Q2 results overview 2014
 
Qliro Group Q4 and year-end results 2016
Qliro Group Q4 and year-end  results 2016Qliro Group Q4 and year-end  results 2016
Qliro Group Q4 and year-end results 2016
 
Brph apresentação call 3 q14 (eng)
Brph apresentação call 3 q14 (eng)Brph apresentação call 3 q14 (eng)
Brph apresentação call 3 q14 (eng)
 
Press release presentation 3 q15
Press release presentation 3 q15Press release presentation 3 q15
Press release presentation 3 q15
 
Gafisa 1 q14 teleconf eng vf (1)
Gafisa 1 q14 teleconf  eng vf (1)Gafisa 1 q14 teleconf  eng vf (1)
Gafisa 1 q14 teleconf eng vf (1)
 
4 t15 arezzo_apresentacao_call ing
4 t15 arezzo_apresentacao_call ing4 t15 arezzo_apresentacao_call ing
4 t15 arezzo_apresentacao_call ing
 
Current Years Estimation PowerPoint Presentation Slides
Current Years Estimation PowerPoint Presentation SlidesCurrent Years Estimation PowerPoint Presentation Slides
Current Years Estimation PowerPoint Presentation Slides
 
Estácio: 2Q16 Conference Call Presentation
Estácio: 2Q16 Conference Call PresentationEstácio: 2Q16 Conference Call Presentation
Estácio: 2Q16 Conference Call Presentation
 

Recently uploaded

Shrambal_Distributors_Newsletter_May-2024.pdf
Shrambal_Distributors_Newsletter_May-2024.pdfShrambal_Distributors_Newsletter_May-2024.pdf
Shrambal_Distributors_Newsletter_May-2024.pdfvikashdidwania1
 
Test bank for advanced assessment interpreting findings and formulating diffe...
Test bank for advanced assessment interpreting findings and formulating diffe...Test bank for advanced assessment interpreting findings and formulating diffe...
Test bank for advanced assessment interpreting findings and formulating diffe...robinsonayot
 
Famous Kala Jadu, Kala ilam specialist in USA and Bangali Amil baba in Saudi ...
Famous Kala Jadu, Kala ilam specialist in USA and Bangali Amil baba in Saudi ...Famous Kala Jadu, Kala ilam specialist in USA and Bangali Amil baba in Saudi ...
Famous Kala Jadu, Kala ilam specialist in USA and Bangali Amil baba in Saudi ...mazhshah570
 
Bank of Tomorrow White Paper For Reading
Bank of Tomorrow White Paper For ReadingBank of Tomorrow White Paper For Reading
Bank of Tomorrow White Paper For ReadingNghiaPham100
 
Lion One Corporate Presentation May 2024
Lion One Corporate Presentation May 2024Lion One Corporate Presentation May 2024
Lion One Corporate Presentation May 2024Adnet Communications
 
Certified Kala Jadu, Black magic specialist in Rawalpindi and Bangali Amil ba...
Certified Kala Jadu, Black magic specialist in Rawalpindi and Bangali Amil ba...Certified Kala Jadu, Black magic specialist in Rawalpindi and Bangali Amil ba...
Certified Kala Jadu, Black magic specialist in Rawalpindi and Bangali Amil ba...batoole333
 
No 1 Top Love marriage specialist baba ji amil baba kala ilam powerful vashik...
No 1 Top Love marriage specialist baba ji amil baba kala ilam powerful vashik...No 1 Top Love marriage specialist baba ji amil baba kala ilam powerful vashik...
No 1 Top Love marriage specialist baba ji amil baba kala ilam powerful vashik...batoole333
 
Famous Kala Jadu, Black magic expert in Faisalabad and Kala ilam specialist i...
Famous Kala Jadu, Black magic expert in Faisalabad and Kala ilam specialist i...Famous Kala Jadu, Black magic expert in Faisalabad and Kala ilam specialist i...
Famous Kala Jadu, Black magic expert in Faisalabad and Kala ilam specialist i...batoole333
 
MalaysianStates_AnalysisGDPandInvestment_web (1).pdf
MalaysianStates_AnalysisGDPandInvestment_web (1).pdfMalaysianStates_AnalysisGDPandInvestment_web (1).pdf
MalaysianStates_AnalysisGDPandInvestment_web (1).pdfJkJeeks
 
Jual obat aborsi Jogja ( 085657271886 ) Cytote pil telat bulan penggugur kand...
Jual obat aborsi Jogja ( 085657271886 ) Cytote pil telat bulan penggugur kand...Jual obat aborsi Jogja ( 085657271886 ) Cytote pil telat bulan penggugur kand...
Jual obat aborsi Jogja ( 085657271886 ) Cytote pil telat bulan penggugur kand...Klinik kandungan
 
uk-no 1 kala ilam expert specialist in uk and qatar kala ilam expert speciali...
uk-no 1 kala ilam expert specialist in uk and qatar kala ilam expert speciali...uk-no 1 kala ilam expert specialist in uk and qatar kala ilam expert speciali...
uk-no 1 kala ilam expert specialist in uk and qatar kala ilam expert speciali...batoole333
 
GIFT City Overview India's Gateway to Global Finance
GIFT City Overview  India's Gateway to Global FinanceGIFT City Overview  India's Gateway to Global Finance
GIFT City Overview India's Gateway to Global FinanceGaurav Kanudawala
 
20240514-Calibre-Q1-2024-Conference-Call-Presentation.pdf
20240514-Calibre-Q1-2024-Conference-Call-Presentation.pdf20240514-Calibre-Q1-2024-Conference-Call-Presentation.pdf
20240514-Calibre-Q1-2024-Conference-Call-Presentation.pdfAdnet Communications
 
najoomi asli amil baba kala jadu expert rawalpindi bangladesh uk usa
najoomi asli amil baba kala jadu expert rawalpindi bangladesh uk usanajoomi asli amil baba kala jadu expert rawalpindi bangladesh uk usa
najoomi asli amil baba kala jadu expert rawalpindi bangladesh uk usamazhshah570
 
black magic removal amil baba in pakistan karachi islamabad america canada uk...
black magic removal amil baba in pakistan karachi islamabad america canada uk...black magic removal amil baba in pakistan karachi islamabad america canada uk...
black magic removal amil baba in pakistan karachi islamabad america canada uk...batoole333
 
Solution Manual For Financial Statement Analysis, 13th Edition By Charles H. ...
Solution Manual For Financial Statement Analysis, 13th Edition By Charles H. ...Solution Manual For Financial Statement Analysis, 13th Edition By Charles H. ...
Solution Manual For Financial Statement Analysis, 13th Edition By Charles H. ...rightmanforbloodline
 
Black magic specialist in Canada (Kala ilam specialist in UK) Bangali Amil ba...
Black magic specialist in Canada (Kala ilam specialist in UK) Bangali Amil ba...Black magic specialist in Canada (Kala ilam specialist in UK) Bangali Amil ba...
Black magic specialist in Canada (Kala ilam specialist in UK) Bangali Amil ba...batoole333
 
fundamentals of corporate finance 11th canadian edition test bank.docx
fundamentals of corporate finance 11th canadian edition test bank.docxfundamentals of corporate finance 11th canadian edition test bank.docx
fundamentals of corporate finance 11th canadian edition test bank.docxssuserf63bd7
 
najoomi asli amil baba kala jadu expert rawalpindi bangladesh uk usa
najoomi asli amil baba kala jadu expert rawalpindi bangladesh uk usanajoomi asli amil baba kala jadu expert rawalpindi bangladesh uk usa
najoomi asli amil baba kala jadu expert rawalpindi bangladesh uk usabatoole333
 

Recently uploaded (20)

Shrambal_Distributors_Newsletter_May-2024.pdf
Shrambal_Distributors_Newsletter_May-2024.pdfShrambal_Distributors_Newsletter_May-2024.pdf
Shrambal_Distributors_Newsletter_May-2024.pdf
 
Test bank for advanced assessment interpreting findings and formulating diffe...
Test bank for advanced assessment interpreting findings and formulating diffe...Test bank for advanced assessment interpreting findings and formulating diffe...
Test bank for advanced assessment interpreting findings and formulating diffe...
 
Famous Kala Jadu, Kala ilam specialist in USA and Bangali Amil baba in Saudi ...
Famous Kala Jadu, Kala ilam specialist in USA and Bangali Amil baba in Saudi ...Famous Kala Jadu, Kala ilam specialist in USA and Bangali Amil baba in Saudi ...
Famous Kala Jadu, Kala ilam specialist in USA and Bangali Amil baba in Saudi ...
 
DIGITAL COMMERCE SHAPE VIETNAMESE SHOPPING HABIT IN 4.0 INDUSTRY
DIGITAL COMMERCE SHAPE VIETNAMESE SHOPPING HABIT IN 4.0 INDUSTRYDIGITAL COMMERCE SHAPE VIETNAMESE SHOPPING HABIT IN 4.0 INDUSTRY
DIGITAL COMMERCE SHAPE VIETNAMESE SHOPPING HABIT IN 4.0 INDUSTRY
 
Bank of Tomorrow White Paper For Reading
Bank of Tomorrow White Paper For ReadingBank of Tomorrow White Paper For Reading
Bank of Tomorrow White Paper For Reading
 
Lion One Corporate Presentation May 2024
Lion One Corporate Presentation May 2024Lion One Corporate Presentation May 2024
Lion One Corporate Presentation May 2024
 
Certified Kala Jadu, Black magic specialist in Rawalpindi and Bangali Amil ba...
Certified Kala Jadu, Black magic specialist in Rawalpindi and Bangali Amil ba...Certified Kala Jadu, Black magic specialist in Rawalpindi and Bangali Amil ba...
Certified Kala Jadu, Black magic specialist in Rawalpindi and Bangali Amil ba...
 
No 1 Top Love marriage specialist baba ji amil baba kala ilam powerful vashik...
No 1 Top Love marriage specialist baba ji amil baba kala ilam powerful vashik...No 1 Top Love marriage specialist baba ji amil baba kala ilam powerful vashik...
No 1 Top Love marriage specialist baba ji amil baba kala ilam powerful vashik...
 
Famous Kala Jadu, Black magic expert in Faisalabad and Kala ilam specialist i...
Famous Kala Jadu, Black magic expert in Faisalabad and Kala ilam specialist i...Famous Kala Jadu, Black magic expert in Faisalabad and Kala ilam specialist i...
Famous Kala Jadu, Black magic expert in Faisalabad and Kala ilam specialist i...
 
MalaysianStates_AnalysisGDPandInvestment_web (1).pdf
MalaysianStates_AnalysisGDPandInvestment_web (1).pdfMalaysianStates_AnalysisGDPandInvestment_web (1).pdf
MalaysianStates_AnalysisGDPandInvestment_web (1).pdf
 
Jual obat aborsi Jogja ( 085657271886 ) Cytote pil telat bulan penggugur kand...
Jual obat aborsi Jogja ( 085657271886 ) Cytote pil telat bulan penggugur kand...Jual obat aborsi Jogja ( 085657271886 ) Cytote pil telat bulan penggugur kand...
Jual obat aborsi Jogja ( 085657271886 ) Cytote pil telat bulan penggugur kand...
 
uk-no 1 kala ilam expert specialist in uk and qatar kala ilam expert speciali...
uk-no 1 kala ilam expert specialist in uk and qatar kala ilam expert speciali...uk-no 1 kala ilam expert specialist in uk and qatar kala ilam expert speciali...
uk-no 1 kala ilam expert specialist in uk and qatar kala ilam expert speciali...
 
GIFT City Overview India's Gateway to Global Finance
GIFT City Overview  India's Gateway to Global FinanceGIFT City Overview  India's Gateway to Global Finance
GIFT City Overview India's Gateway to Global Finance
 
20240514-Calibre-Q1-2024-Conference-Call-Presentation.pdf
20240514-Calibre-Q1-2024-Conference-Call-Presentation.pdf20240514-Calibre-Q1-2024-Conference-Call-Presentation.pdf
20240514-Calibre-Q1-2024-Conference-Call-Presentation.pdf
 
najoomi asli amil baba kala jadu expert rawalpindi bangladesh uk usa
najoomi asli amil baba kala jadu expert rawalpindi bangladesh uk usanajoomi asli amil baba kala jadu expert rawalpindi bangladesh uk usa
najoomi asli amil baba kala jadu expert rawalpindi bangladesh uk usa
 
black magic removal amil baba in pakistan karachi islamabad america canada uk...
black magic removal amil baba in pakistan karachi islamabad america canada uk...black magic removal amil baba in pakistan karachi islamabad america canada uk...
black magic removal amil baba in pakistan karachi islamabad america canada uk...
 
Solution Manual For Financial Statement Analysis, 13th Edition By Charles H. ...
Solution Manual For Financial Statement Analysis, 13th Edition By Charles H. ...Solution Manual For Financial Statement Analysis, 13th Edition By Charles H. ...
Solution Manual For Financial Statement Analysis, 13th Edition By Charles H. ...
 
Black magic specialist in Canada (Kala ilam specialist in UK) Bangali Amil ba...
Black magic specialist in Canada (Kala ilam specialist in UK) Bangali Amil ba...Black magic specialist in Canada (Kala ilam specialist in UK) Bangali Amil ba...
Black magic specialist in Canada (Kala ilam specialist in UK) Bangali Amil ba...
 
fundamentals of corporate finance 11th canadian edition test bank.docx
fundamentals of corporate finance 11th canadian edition test bank.docxfundamentals of corporate finance 11th canadian edition test bank.docx
fundamentals of corporate finance 11th canadian edition test bank.docx
 
najoomi asli amil baba kala jadu expert rawalpindi bangladesh uk usa
najoomi asli amil baba kala jadu expert rawalpindi bangladesh uk usanajoomi asli amil baba kala jadu expert rawalpindi bangladesh uk usa
najoomi asli amil baba kala jadu expert rawalpindi bangladesh uk usa
 

Brph apresentação call 2 t13 (eng) v2

  • 1. 2Q13 Conference Call Presentation August 15, 2013
  • 2. • Gross revenues of R$845.4 million, an increase of 13.2% over 2Q12. • Gross Margin of 31.5%, 1.4 p.p. over 2Q12 • Total SSS (same-store sales) of 9.8%, with 5.3% for mature stores • Adjusted EBITDA of R$48.4 million, with adjusted EBITDA margin of 5.7% • Adjusted net income of R$7.9 million, with adjusted net margin of 0.9% • With the opening of 25 new owned stores and 27 franchisees, we ended 2Q13 with 1,160 stores. • Inauguration of a new distribution center in Recife Operational & Financial
  • 3. 250 Owned stores 121 Owned stores 143 Owned stores 433 Franchises 213 Owned stores 727 Owned stores 433 Franchises 1,160 stores REGIONS Owned stores North 128 Northeast 249 Midwest 137 Southeast South 213 15 2 120 20 15 28 13 201 8 69 122 1 12 5 Distribution centers 95 6 National Footprint
  • 4.  25 openings (34 in 1H13) 7 closings (15 in 1H13)  39.5% of owned stores not yet at mature stage 25 7 12.4% 14.4% 12.7%60.5% Stores with less than 12 months Stores with 12 to 24 months Stores with 24 to 36 months Stores with more than 36 months
  • 5. • 27 openings in 2Q13 • Accelerated expansion plan
  • 6. 18.4% 12.0% 24.0% 14.0% 1H12 1H13 Abrafarma chains Brasil Pharma 746.9 845.4 1,446.2 1,648.9 2Q12 2Q13 1H12 1H13 13.8% 9.8% 9.1% 5.3% 2Q12 2Q13 SSS Total SSS mature stores (36 months or older) 10.2% 9.8% 9.3% 8.0% 6.9% 4.3% 3.7% 3.0% 0.6% -19.0%
  • 7. Generic penetration in medicine sales 36.5% 37.1% 38.4% 37.9% 37.6% 17.1% 17.0% 16.4% 16.5% 16.9% 46.4% 45.9% 45.2% 45.6% 45.5% 2Q12 3Q12 4Q12 1Q13 2Q13 Non-medicines Generic Medicine Branded medicine 31.4 33.8 2Q12 2Q13
  • 8. • Higher “pre- increase” effect in 2Q13 compared to 2Q12 • Distribution Center in Bahia 224.5 266.0 435.5 499.0 30.1% 31.5% 30.1% 30.3% 2Q12 2Q13 1H12 1H13
  • 9. 51,9 51,0 103,4 99,1 126,2 166,6 249,0 316,7178,1 217,6 352,3 415,8 2Q12 2Q13 1H12 1H13 General & Administrative Sales expenses 6,9% 6,0% 7,1% 6,0% 16,9% 19,7% 17,2% 19,2% 23,8% 25,7% 24,4% 25,2% 2Q12 2Q13 1H12 1H13 G&A % Sales expenses % SG&A total % 2Q12 2Q13 1H12 1H13 Proforma Gross Revenues 746,855 845,424 1,446,204 1,648,891 General and administrative expenses (G&A) (51,889) (50,994) (103,353) (99,117) % Gross Revenues 6.9% 6.0% 7.1% 6.0% G&ADilution (R$'000)
  • 10. 1H12 1H13 Proforma Proforma Non recurring SG&A (3,721) - 14,513 (2,594) IPO /Debenture issuance expenses - (108) - M&A/Branding (397) (2,204) (684) Income related to Santana insurance - 21,653 - Platforms Integration/Downsizing (3,324) (4,828) (1,763) Other - - (147) Non recurring expenses (R$'000) 2Q12 2Q13
  • 11. 46,3 48,4 83,2 83,2 6,2% 5,7% 5,8% 5,0% 2Q12 2Q13 1H12 1H13 24,3 7,9 34,4 10,4 3,2% 0,9% 2,4% 0,6% 2Q12 2Q13 1H12 1H13
  • 12. Cash position and indebtedness (R$'000) 2Q12 4Q12 1Q13 2Q13 (+) Loans and financing 159,908 177,049 169,079 160,228 Short term 48,123 83,229 44,864 41,694 Long term 111,785 93,820 124,215 118,534 (+) Debentures 254,879 253,642 258,937 253,964 Short term 6,688 5,237 10,427 5,348 Long term 248,191 248,405 248,510 248,616 (+) Accounts payable for investment acquisition 498,242 345,333 264,430 232,581 Short term 244,986 99,711 82,833 81,986 Long term 253,256 245,622 181,597 150,595 (=) Total Indebtedness 913,029 776,024 692,446 646,773 Short term (%) 32.8% 24.2% 19.9% 19.9% Long term (%) 67.2% 75.8% 80.1% 80.1% (-) Cash and cash equivalents (411,267) (368,751) (183,870) (162,205) (=) Net Debt 501,762 407,273 508,576 484,568 Net debt/Adjusted EBITDA (LTM) 2.9 X 2.1 X 2.7 X 2.5 X
  • 13. 746 6 27 12 23 Working capial 2Q12 4Q12 1Q13 2Q13 Accounts receivable 25 23 24 18 Inventories 92 95 106 109 Suppliers 54 58 55 73 Working capital in days 63 60 75 53
  • 14. Cash flow Statement (R$'000) 2Q12 2Q13 1H12 1H13 EBT 7,795 11,158 18,021 3,605 (+) Depreciation and amortization 12,268 17,054 28,360 33,516 (+) Others 12,896 (4,175) 26,038 20,214- - Operating cash generation 32,959 24,037 72,419 57,335 (+) Change in working capital (93,559) 159,077 (151,092) 75,935 (+) Change in other assets and liabilities (41,623) (104,886) (55,541) (118,669) Cash consumption (135,182) 54,191 (206,633) (42,734) Net cash generated by operating activities (102,223) 78,228 (134,214) 14,601 (-) Capex from operations (28,176) (49,033) (47,723) (73,953) (-) Acquisitions (41,566) (31,848) (327,898) (112,751) Net Cash from investing activities (69,742) (80,881) (375,621) (186,704) (+/-) Loans and financing 62,480 (25,986) 258,755 (41,417) (+) Equity funding / Dividends 397,851 6,975 398,792 6,975 Net Cash from financing activities 460,331 (19,011) 657,547 (34,442) Change in cash and cash equivalents 288,366 (21,664) 147,712 (206,545) Cash and cash equivalents - opening balance 122,901 183,870 263,555 368,751 Cash and cash equivalents - closing balance 411,267 162,205 411,267 162,205
  • 15. Back-Office Adm. (SSC) SAP - Back-Office Operation integrated (SSC). Continuous improvement phase Pre-"Go Live" tests cycle Will be integrated in 2014 Mapping phase and "Go live" in 2014 Operation integrated (SSC). Continuous improvement phase Pre-"Go Live" tests cycle Operation integrated (SSC). Continuous improvement phase Pre-"Go Live" tests cycle Status 75% 50% Administrative (SSC)
  • 16. Logistics Trade Marketing Procurement New DC (Nov 2012) Stores remodeling (2012): 28% increase in HPC Procurement integrated New DC (Jun 2013) Actions to improve generics sales in practice Procurement Integration expected to 2014 New DC FC (Out 2013) Focus in remodeling to standardize mix and layout Procurement integrated New DC (Out 2012) Mix and store layout standardized Procurement integrated Status 70% 60% 60% Commercial
  • 17. Sales Training Culture Meritocracy POS system Growth strategy "Vendo Mais" Program in practice New Brasil Pharma logo (endorsement) Standardization of variable compensation implemented Unique system under analysis Store openings: countryside of Bahia "Vendo Mais" Program in practice New Brasil Pharma logo (endorsement) Standardization of variable compensation to be implemented Unique system under analysis Store openings in N/NE "Vendo Mais" Program in practice New Brasil Pharma logo (endorsement) Standardization of variable compensation implemented Unique system under analysis Store closings: sales bellow BRPH average "Vendo Mais" Program in practice New Brasil Pharma logo (endorsement) Standardization of variable compensation implemented Unique system under analysis Store openings: countryside of MT and GO Status 100% 100% 80% 0% 80% Operations
  • 18. Jun-11 Jul-11 Aug-11 Sep-11 Oct-11 Nov-11 Dec-11 Jan-12 Feb-12 Mar-12 Apr-12 May-12 Jun-12 Jul-12 Aug-12 Sep-12 Oct-12 Nov-12 Dec-12 Jan-13 Feb-13 Mar-13 Apr-13 May-13 Jun-13 Brasil Pharma IBOV Source: Bloomberg, as of June 30st, 2013. Company’s IPO on June 24, 2011. BPHA3 06.31.13 Market closure Shares outstanding 256,084,419 Price (R$/share) 10.26 Annual Performance -28.8% Ibovespa Index -22.1% Perfomance since IPO¹ 19.0% Ibovespa Index -22.2% Market Cap (R$ Bn) 2.6 Average daily trading volume in 2013 (R$ million) 12.4 BPHA3 06.31.13 Market closure Shares outstanding 256,084,419 Price (R$/share) 10.26 Annual Performance -28.8% Ibovespa Index -22.1% Perfomance since IPO¹ 19.0% Ibovespa Index -22.2% Market Cap (R$ Bn) 2.6 Average daily trading volume in 2013 (R$ million) 12.4 256,384,419 06.30.13